Additionally, 50% of MEN2A patients are primarily diagnosed with MTC without pheochromocytoma, and 40% are diagnosed with pheochromocytoma and MTC concurrently (6). The gene discussed is RET; the disease is hereditary pheochromocytoma-paraganglioma.